We are live on ! Find out more
EPZM

Epizyme, Inc
EPZM

Delisted

EPZM was delisted on the 11th of August, 2022.

Back to rankings

134 hedge funds and large institutions have $1B invested in Epizyme, Inc in 2019 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 53 increasing their positions, 27 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

96% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 27

80% more funds holding in top 10

Funds holding in top 10: 5 → 9 (+4)

68% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 22

11% more funds holding

Funds holding: 121 → 134 (+13)

4% more capital invested

Capital invested by funds: $965M → $1B (+$38M)

67% less call options, than puts

Call options by funds: $687K | Put options by funds: $2.1M

Holders
134
Holders Change
+13
Holders Change %
+10.74%
% of All Funds
2.91%
Holding in Top 10
9
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+80%
% of All Funds
0.2%
New
37
Increased
53
Reduced
27
Closed
22
Calls
$687K
Puts
$2.1M
Net Calls
-$1.42M
Net Calls Change
-$369K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$21M
2
BlackRock
BlackRock
New York
+$20M
3
CCM
Consonance Capital Management
New York
+$16.5M
4
RG
Redmile Group
California
+$13.3M
5
State Street
State Street
Massachusetts
+$10.1M

Top Sellers

Rank Fund Capital Flow
1
NMC
NEA Management Company
Maryland
-$32.2M
2
GPP
Great Point Partners
Connecticut
-$26.9M
3
Millennium Management
Millennium Management
New York
-$13M
4
Jennison Associates
Jennison Associates
New York
-$8.8M
5
VOYA Investment Management
VOYA Investment Management
Georgia
-$4.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
GTC
26
Ghost Tree Capital
New York
$5.84M -$450K -35,000 -7%
Charles Schwab
27
Charles Schwab
California
$5.76M +$991K +77,012 +20%
Renaissance Technologies
28
Renaissance Technologies
New York
$5.42M +$5.56M +431,788 New
TCM
29
Tekla Capital Management
Massachusetts
$5.01M +$1.42M +110,200 +38%
Deutsche Bank
30
Deutsche Bank
Germany
$4.42M +$2.38M +184,709 +110%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$3.98M +$580K +45,110 +17%
N
32
Nuveen
North Carolina
$3.96M +$4.06M +315,561 New
Morgan Stanley
33
Morgan Stanley
New York
$3.85M -$463K -35,954 -10%
VOYA Investment Management
34
VOYA Investment Management
Georgia
$3.51M -$4.9M -380,766 -58%
EAM
35
Erste Asset Management
Austria
$3.43M -$425K -33,000 -11%
SSA
36
Schonfeld Strategic Advisors
New York
$3.27M -$2M -155,700 -37%
DekaBank Deutsche Girozentrale
37
DekaBank Deutsche Girozentrale
Germany
$2.91M +$2.14M +166,100 +230%
California Public Employees Retirement System
38
California Public Employees Retirement System
California
$2.89M -$28.4K -2,210 -1%
Macquarie Group
39
Macquarie Group
Australia
$2.55M – – –
FLAM
40
First Light Asset Management
Minnesota
$2.51M +$2.57M +200,063 New
AI
41
Atom Investors
Texas
$2.44M +$2.5M +194,094 New
PP
42
PDT Partners
New York
$2.43M +$532K +41,372 +27%
AA
43
ALPS Advisors
Colorado
$2.39M +$2.45M +190,125 New
DCM
44
DAFNA Capital Management
California
$2.18M +$2.23M +173,536 New
DC
45
Diametric Capital
Massachusetts
$1.97M +$2.01M +156,575 New
Rafferty Asset Management
46
Rafferty Asset Management
New York
$1.69M +$673K +52,289 +64%
Swiss National Bank
47
Swiss National Bank
Switzerland
$1.67M +$30.9K +2,400 +2%
GA
48
Greenspring Associates
Maryland
$1.64M +$1.68M +130,411 New
Teacher Retirement System of Texas
49
Teacher Retirement System of Texas
Texas
$1.6M +$1.36M +105,889 New
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$1.55M +$255K +19,810 +19%
1
2
3 4 5

EPZM Hedge Fund Activity: Q2 2019 in Review

134 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Epizyme, Inc (EPZM) for Q2 2019, worth a combined $1B — up 3.9% from $965M a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new EPZM positions and 22 closed out — a net gain of 15 holders — while 53 added to existing stakes and 27 trimmed.

The largest buyer was Vanguard Group, adding an estimated $21M. The largest seller was NEA Management Company, cutting an estimated $32.2M.

  • 134 institutional investors held Epizyme, Inc (EPZM) as of Q2 2019, up from 121 in Q1 2019.
  • Funds reported $1B of Epizyme, Inc stock for Q2 2019, up 3.9% quarter-over-quarter.
  • 37 funds opened new Epizyme, Inc positions in Q2 2019 and 22 closed out, a net change of +15 holders.
  • The largest Epizyme, Inc buyer in Q2 2019 was Vanguard Group, an estimated $21M added.
  • The largest Epizyme, Inc seller in Q2 2019 was NEA Management Company, an estimated $32.2M sold.

Based on aggregated 13F filings for Q2 2019.